This work aimed to evaluate the effects of Metarhizium anisopliae on Diatraea flavipennella and investigate their immune response. Was observed the effect of M. anisopliae against larvae of D. flavipennella sprayed at concentrations of 10 3 , 10 4 , 10 5 conidia / mL, in which showed differences relative the larval period, extending up to 72.0 days in treatment and 25.0 days in the control. The results for hemocytes revealed that the most frequent cells when sprayed at the concentrations of 10 3 , 10 5 , 10 7 conidia / mL were the prohemocytes, spherulocytes, plasmatocytes and granulocytes in relation to adipohemocytes and oenocytoids. The level of nitric oxide was different between the control and the concentration 10 7 spores / mL (24), while the activity of phenoloxidase was similar among treatments in 24 and higher concentration 10 7 spores / mL (60h). In biochemical profile of hemocytes was a change in carbohydrates, lipids and proteins in response to the fungus. The results indicate that the fungus M. anisopliae can be used in the Integrated Management of D. flavipennella by presenting pathogenicity and interfere with their development even when exposed to small concentrations.
RESUMOResults show that in treatments in which M. anisopliae was used, caused high mortality, was used there was not parasitoid development, occurring mortality only by the fungus. However, in treatments that used B. bassiana there was parasitoid development, causing mortality in larvae by the fungus and by the parasitoid. However, B. bassiana and M. anisopliae must be used with care in Integrated Pest Management in which C. flavipes parasitoid is also used, because fungi can affect the parasitoid development.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.